Influenza vaccination in autoimmune rheumatic disease patients

Tohoku Journal of Experimental Medicine

Volumn 229, Issue 1, 2012, Pages 29-34

  Milanovic, Milomir ^a   Stojanovich, Ljudmila ^b   Djokovic, Aleksandra ^b   Kontic, Milica ^c   Gvozdenovic, Eleonora ^d  

^a UNIVERSITY OF DEFENCE   (Serbia)

^b Clinic for Oncology   (Serbia)

^c CLINICAL CENTER OF SERBIA   (Serbia)

^d UNIVERSITY OF BELGRADE   (Serbia)

Author keywords

Autoimmune rheumatic disease; Efficiency; Influenza vaccine; Respiratory infections; Safety

Indexed keywords

CORTICOSTEROID; HYDROXYCHLOROQUINE; INFLUENZA VACCINE; METHOTREXATE; VIRUS ANTIBODY;

ADULT; AGE; ANTIBODY TITER; ARTICLE; AUTOIMMUNE DISEASE; BACTERIAL INFECTION; BRONCHITIS; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DISEASE ACTIVITY; DISEASE DURATION; DISEASE EXACERBATION; DISEASE PREDISPOSITION; DRUG SAFETY; DRUG UTILIZATION; FEMALE; HUMAN; HUMORAL IMMUNITY; IMMUNOGENICITY; INCIDENCE; INFECTION RISK; INFLUENZA; INFLUENZA VIRUS A H1N1; MAJOR CLINICAL STUDY; MALE; PNEUMONIA; RESPIRATORY TRACT INFECTION; RHEUMATIC DISEASE; RHEUMATOID ARTHRITIS; RISK REDUCTION; SEX DIFFERENCE; SJOEGREN SYNDROME; SMOKING; SYSTEMIC LUPUS ERYTHEMATOSUS; TREATMENT REFUSAL;

ANTIBODIES, VIRAL; ARTHRITIS, RHEUMATOID; CROSS-SECTIONAL STUDIES; FEMALE; HEMAGGLUTINATION INHIBITION TESTS; HUMANS; INCIDENCE; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA VACCINES; INFLUENZA, HUMAN; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; RISK FACTORS; SJOGREN'S SYNDROME; TREATMENT OUTCOME;

EID: 84873035103     PISSN: 00408727     EISSN: 13493329     Source Type: Journal    
DOI: 10.1620/tjem.229.29     Document Type: Article

References (33)

1. Abu-Shakra, M., Press, J., Varsano, N., Levy, V., Mendelson, E., Sukenik, S. & Buskila, D. (2002) Specific antibody response after influenza immunization in systemic lupus erythematosus. J. Rheumatol., 29, 2555-2557.
2. Aron-Maor, A. & Shoenfeld, Y. (2004) Vaccination and autoimmunity. In: Infection and autoimmunity, edited by Shoenfeld, Y. & Rose, N.R., Elsevier B.V., New York, NY, pp. 105-116.
3. Avery, R.K. (1999) Vaccination of the immunosuppressed adult patient with rheumatologic disease. Rheum. Dis. Clin. North. Am., 25, 567-584.
4. Bosch, X., Guilabert, A., Pallarés, L., Cerveral, R., Ramos-Casals, M., Bové, A., Ingelmo, M. & Font, J. (2006) Infections in systemic lupus erythematosus: a prospective and controlled study of 110 patients. Lupus, 15, 584-589.
5. Brodman, R., Gilfillan, R., Glass, D. & Schur, P.H. (1978) Influenzal vaccine response in systemic lupus erythematosus. Ann. Intern. Med., 88, 735-740.
6. Cervera, R., Khamashta, M.A., Font, J., Sebastiani, G.D., Gil, A., Lavilla, P., Mejía, J.C., Aydintug, A.O., Chwalinska-Sadowska, H., de Ramón, E., Fernández-Nebro, A., Galeazzi, M., Valen, M., Mathieu, A., Houssiau, F., Caro, N., Alba, P., Ramos-Casals, M., Ingelmo, M. & Hughes, G.R.; European Working Party on Systemic Lupus Erythematosus. (2003) Morbidity and mortality in systemic lupus erythematosus during a 10-year period: a comparison of early and late manifestations in a cohort of 1000 patient. Medicine (Baltimore), 82, 299-308.
7. Conti, F., Rezai, S. & Valesini, G. (2008) Vaccination and autoimmune rheumatic diseases. Autoimmun. Rev., 8, 124-128.
8. Del Porto, F., Laganà, B., Biselli, R., Donatelli, I., Campitelli, L., Nisini, R., Cardelli, P., Rossi, F. & D'Amelio, R. (2006) Influenza vaccine administration in patients with systemic lupus erythematosus and rheumatoid arthritis. Safety and immunogenicity. Vaccine, 24, 3217-3223.
9. Doran, M.F., Crowson, C.S., Pond, G.R., O'Fallon, W.M. & Gabriel, S.E. (2002) Frequency of infection in patients with rheumatoid arthritis compared with controls: a populationbased study. Arthritis Rheum., 46, 2287-2293.
10. Elkayam, O. (2006) Safety and efficacy of vaccination against influenza in patients with rheumatoid arthritis. Clin. Dev. Immunol., 13, 349-351.
11. Falagas, M.E., Manta, K.G., Betsi, G.I. & Pappas, G. (2007) Infection-related morbidity and mortality in patients with connective tissue diseases: a systematic review. Clin. Rheumatol., 26, 663-670.
12. Fomin, I., Caspi, D., Levy, V., Varsano, N., Shalev, Y., Paran, D., Levartovsky, D., Litinsky, I., Kaufman, I., Wigler, I., Mendelson, E. & Elkayam, O. (2006) Vaccination against influenza in rheumatoid arthritis: the effect of disease modifying drugs, including TNF alpha blockers. Ann. Rheum. Dis., 65, 191-194.
13. Gelinck, L.B., van der Bijl, A.E., Beyer, W.E., Visser, L.G., Huizinga, T.W., van Hogezand, R.A., Rimmelzwaan, G.F. & Kroon, F.P. (2008) The effect of anti-tumor necrosis factor alpha treatment on the antibody response to influenza vaccination. Ann. Rheum. Dis., 67, 713-716.
14. Glück, T. (2006) Vaccinate your immunocompromised patients! Rheumatology (Oxford)., 45, 9-10.
15. Glück, T. & Müller-Ladner, U. (2008) Vaccination in patients with chronic rheumatic or autoimmune diseases. Clin. Infect. Dis., 46, 1459-1465.
16. Holvast, A., Huckriede, A., Wilschut, J., Horst, G., De Vries, J.J., Benne, C.A., Kallenberg, C.G. & Bijl, M. (2006) Safety and efficacy of influenza vaccination in systemic lupus erythematosus patients with quiescent disease. Ann. Rheum. Dis., 65, 913-918.
17. Leslie, K.O., Trahan, S. & Gruden, J. (2007) Pulmonary pathology of the rheumatic diseases. Semin. Respir. Crit. Care Med., 28, 369-378.
18. Louie, J.S., Nies, K.M., Shoji, K.T., Fraback, R.C., Abrass, C., Border, W., Cherry, J.D. & Imagawa, D. (1978) Clinical and antibody responces after influenza immunization in systemic lupus erythematosus. Ann. Intern. Med., 88, 790-792.
19. Lu, C.C., Wang, Y.C., Lai, J.H., Lee, T.S., Lin, H.T. & Chang, D.M. (2011) A/H1N1 influenza vaccination in patients with systemic lupus erythematosus: safety and immunity. Vaccine, 29, 444-450.
20. Mandell, G.L., Bennett, J.E. & Dolan, R. (2010) Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases, 7th ed., Churchill Livingstone Elsevier, Philadelphia, PA.
21. Mercado, U., Acosta, H. & Avendaño, L. (2004) Influenza vaccination of patients with systemic lupus erythematosus. Rev. Invest. Clin., 56, 16-20.
22. Nossal, G.J. (2000) Vaccination and autoimmunity. J. Autoimmun., 14, 13-15.
23. Rahier, J.F., Moutschen, M., Van Gompel, A., Van Ranst, M., Louis, E., Segaert, S., Masson, P. & De Keyser, F. (2010) Vaccinations in patients with immune-mediated inflammatory diseases. Rheumatology (Oxford), 49, 1815-1827.
24. Rose, N.R. (1998) The role of infection in the pathogenesis of autoimmune disease. Semin. Immunol., 10, 5-13.
25. Saad, C.G., Borba, E.F., Aikawa, N.E., Silva, C.A., Pereira, R.M., Calich, A.L., Moraes, J.C., Ribeiro, A.C., Viana, V.S., Pasoto, S.G., Carvalho, J.F., França, I.L., Guedes, L.K., Shinjo, S.K., Sampaio-Barros, P.D., Caleiro, M.T., Goncalves, C.R., Fuller, R., Levy-Neto, M., Timenetsky Mdo, C., Precioso, A.R. & Bonfa, E. (2011) Immunogenicity and safety of the 2009 nonadjuvanted influenza A/H1N1 vaccine in a large cohort of autoimmune rheumatic diseases. Ann. Rheum. Dis., 70, 1068-1073.
26. Shoenfeld, Y. & Rose, N.R. (2004) Infection and autoimmunity. Elsevier Publ, Amsterdam, The Netherlands. pp. 1-747
27. Stojanovich, L. (2006) Influenza vaccination of patients with systemic lupus erythematosus (SLE) and rheumatoid arthritis (RA). Clin. Dev. Immunol., 13, 373-375.
28. Turner-Stokes, L., Cambridge, G., Corcoran Oxford, J.S. & Snaith, M.L. (1988) In vitro response to influenza immunisation by peripheral blood mononuclear cells from patients with systemic lupus erythematosus and other autoimmune diseases. Ann. Rheum. Dis., 47, 532-535.
29. van Assen, S. (2011) Influenza vaccination in primary and secondary immunodeficiencies. Ipskamp Drukkers, Enschede, The Netherlands. pp. 1-227.
30. van Assen, S., Agmon-Levin, N., Elkayam, O., Cervera, R., Doran, M.F., Dougados, M., Emery, P., Geborek, P., Ioannidis, J.P., Jayne, D.R., Kallenberg, C.G., Müller-Ladner, U., Shoenfeld, Y., Stojanovich, L., Valesini, G., Wulffraat, N.M. & Bijl, M. (2011a) EULAR recommendations for vaccination in adult patients with autoimmune inflammatory rheumatic diseases. Ann. Rheum. Dis., 70, 414-422.
31. van Assen, S., Elkayam, O., Agmon-Levin, N., Cervera, R., Doran, M.F., Dougados, M., Emery, P., Geborek, P., Ioannidis, J.P., Jayne, D.R., Kallenberg, C.G., Müller-Ladner, U., Shoenfeld, Y., Stojanovich, L., Valesini, G., Wulffraat, N.M. & Bijl, M. (2011b) Vaccination in adult patients with auto-immune inflammatory rheumatic diseases: a systematic literature review for the European League Against Rheumatism evidence-based recommendations for vaccination in adult patients with auto-immune inflammatory rheumatic diseases. Autoimmun. Rev., 10, 341-352.
32. van Assen, S., Holvast, A., Benne, C.A., Posthumus, M.D., van Leeuwen, M.A., Voskuyl, A.E., Blom, M., Risselada, A.P., de Haan, A., Westra, J., Kallenberg, C.G. & Bijl, M. (2010) Humoral responces after influenza vaccination are severely reduced in patients with rheumatoid arthritis treated with rituximab. Arthritis Rheum., 62, 75-81.
33. Wiesik-Szewczyk, E., Romanowska, M., Mielnik, P., Chwalińska-Sadowska, H., Brydak, L.B., Olesińska, M. & Zabek, J. (2010) Anti-influenza vaccination in systemic lupus erythematosus patients: an analysis of specific humoral response and vaccination safety. Clin. Rheumatol., 29, 605-613.